Tyropanoic acid
 | |
 | |
| Names | |
|---|---|
| IUPAC name
2-[(3-butanamido-2,4,6-triiodophenyl)methyl]butanoic acid | |
| Other names
2-[[2,4,6-triiodo-3-(1-oxobutylamino)phenyl]methyl]butanoic acid | |
| Identifiers | |
27293-82-9  | |
| 3D model (Jmol) | Interactive image |
| ChEMBL | ChEMBL1201261  |
| ECHA InfoCard | 100.043.976 |
| PubChem | 5611 |
| |
| Properties | |
| C15H18I3NO3 | |
| Molar mass | 641.02 g/mol |
| Pharmacology | |
| V08AC09 (WHO) | |
| Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
| verify (what is ?) | |
| Infobox references | |
Tyropanoic acid and its salt sodium tyropanoate are radiocontrast agents used in cholecystography (X-ray diagnosis of gallstones). Trade names include Bilopaque, Lumopaque, Tyropaque, and Bilopac.[1] The molecule contains three heavy iodine atoms which obstruct X-rays in the same way as the calcium in bones to produce a visible image. After injection it is rapidly excreted into the bile.[2]
References
- ↑ "PubChem CID 5611".
- ↑ "Inhibition of hepatic binding of thyroxine by cholecystographic agents". J. Clin. Invest. 65 (5): 1032–40. May 1980. doi:10.1172/JCI109755. PMC 371433
. PMID 7364937.
This article is issued from Wikipedia - version of the 11/30/2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.